X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Cadila Healthcare with TTK HEALTHCARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs TTK HEALTHCARE - Comparison Results

CADILA HEALTHCARE    Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE TTK HEALTHCARE CADILA HEALTHCARE/
TTK HEALTHCARE
 
P/E (TTM) x 18.1 17.1 105.9% View Chart
P/BV x 4.1 5.6 73.8% View Chart
Dividend Yield % 1.0 0.5 191.1%  

Financials

 CADILA HEALTHCARE   TTK HEALTHCARE
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-18
TTK HEALTHCARE
Mar-14
CADILA HEALTHCARE/
TTK HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs558663 84.1%   
Low Rs362399 90.6%   
Sales per share (Unadj.) Rs116.3535.6 21.7%  
Earnings per share (Unadj.) Rs17.915.9 112.1%  
Cash flow per share (Unadj.) Rs23.120.0 115.5%  
Dividends per share (Unadj.) Rs3.504.00 87.5%  
Dividend yield (eoy) %0.80.8 101.1%  
Book value per share (Unadj.) Rs85.4137.6 62.1%  
Shares outstanding (eoy) m1,023.747.77 13,175.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.01.0 398.6%   
Avg P/E ratio x25.733.3 77.2%  
P/CF ratio (eoy) x19.926.5 74.9%  
Price / Book Value ratio x5.43.9 139.4%  
Dividend payout %19.625.1 78.1%   
Avg Mkt Cap Rs m470,6644,127 11,403.3%   
No. of employees `00011.81.7 692.0%   
Total wages/salary Rs m18,545607 3,057.2%   
Avg. sales/employee Rs Th10,072.72,436.7 413.4%   
Avg. wages/employee Rs Th1,569.1355.2 441.8%   
Avg. net profit/employee Rs Th1,547.772.5 2,133.5%   
INCOME DATA
Net Sales Rs m119,0494,162 2,860.5%  
Other income Rs m1,13261 1,849.7%   
Total revenues Rs m120,1814,223 2,845.9%   
Gross profit Rs m28,475197 14,447.0%  
Depreciation Rs m5,38832 16,996.8%   
Interest Rs m91130 3,046.8%   
Profit before tax Rs m23,308197 11,849.5%   
Minority Interest Rs m6280-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,64473 7,752.7%   
Profit after tax Rs m18,292124 14,763.5%  
Gross profit margin %23.94.7 505.0%  
Effective tax rate %24.237.0 65.4%   
Net profit margin %15.43.0 516.1%  
BALANCE SHEET DATA
Current assets Rs m82,0051,629 5,035.0%   
Current liabilities Rs m60,7201,058 5,740.2%   
Net working cap to sales %17.913.7 130.3%  
Current ratio x1.41.5 87.7%  
Inventory Days Days7330 245.6%  
Debtors Days Days9834 292.7%  
Net fixed assets Rs m83,703556 15,046.4%   
Share capital Rs m1,02478 1,317.9%   
"Free" reserves Rs m86,421878 9,839.6%   
Net worth Rs m87,4451,069 8,177.8%   
Long term debt Rs m25,551159 16,100.2%   
Total assets Rs m180,6532,399 7,529.1%  
Interest coverage x26.67.6 350.8%   
Debt to equity ratio x0.30.1 196.9%  
Sales to assets ratio x0.71.7 38.0%   
Return on assets %10.66.4 165.8%  
Return on equity %20.911.6 180.5%  
Return on capital %22.018.5 119.2%  
Exports to sales %00.8 0.0%   
Imports to sales %01.4 0.0%   
Exports (fob) Rs mNA33 0.0%   
Imports (cif) Rs mNA58 0.0%   
Fx inflow Rs m42,68333 129,735.6%   
Fx outflow Rs m11,24263 17,790.8%   
Net fx Rs m31,441-30 -103,799.9%   
CASH FLOW
From Operations Rs m9,193127 7,261.5%  
From Investments Rs m-9,737-146 6,669.2%  
From Financial Activity Rs m51522 2,351.6%  
Net Cashflow Rs m-293 -1,160.0%  

Share Holding

Indian Promoters % 74.8 65.4 114.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 8.3 3.7 224.3%  
FIIs % 5.9 5.2 113.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 11.0 25.8 42.6%  
Shareholders   44,069 12,723 346.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   FDC LTD.  ALEMBIC LTD  WYETH LTD  AJANTA PHARMA  SUVEN LIFE  

Compare CADILA HEALTHCARE With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 307 Points Higher; Metal and Oil & Gas Stocks Witness Buying(Closing)

Indian share markets traded on a positive note throughout the day and ended on a strong note. Gains were seen in the metal sector.

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (2QFY19); Net Profit Down 15.3% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, TTK HEALTHCARE has posted a net profit of Rs 67 m (down 15.3% YoY). Sales on the other hand came in at Rs 2 bn (up 16.3% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (2QFY19); Net Profit Down 18.6% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, CADILA HEALTHCARE has posted a net profit of Rs 4 bn (down 18.6% YoY). Sales on the other hand came in at Rs 30 bn (down 8.4% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

It's Almost the Perfect Time to Buy This Safe Stock(The 5 Minute Wrapup)

Dec 6, 2018

My latest StockSelect recommendation ticks all the boxes of a great safe stock.

Patel's Exit, Election Results, and 4 'Must Have' Small Caps in These Exceptional Times(Profit Hunter)

Dec 11, 2018

RBI Governor's resignation is a statement of dissent with the way government is handling the economy's affairs and could lead to some serious market correction. Here's how to make the most of it.

Players in an Oligopoly Should Have Financials Like This(Chart Of The Day)

Dec 7, 2018

This stock has corrected 30% from peak and looks attractive at these valuations.

Looking For Higher Interest Rates on Bank FDs? Read This!(Outside View)

Dec 5, 2018

Credit disbursement to the productive sectors of the economy such as infrastructure, engineering, food processing, textiles, and chemicals, among others is rising.

DSP Mutual Fund's Sale of DHFL Bonds: Here's What You Need to Know(Outside View)

Dec 5, 2018

PersonalFN explains the probable reason as to why the capital market regulator has initiated DSP Mutual Fund's bond sale that caused DHFL stock to crash.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Dec 17, 2018 (Close)

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE - DR. DATSONS LABS COMPARISON

COMPARE CADILA HEALTHCARE WITH

MARKET STATS